- Report
- June 2021
Global
From €3528EUR$4,000USD£3,054GBP
- Report
- July 2024
- 100 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- July 2024
- 100 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- July 2024
- 150 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- July 2024
- 100 Pages
Global
From €3307EUR$3,750USD£2,863GBP
- Report
- June 2024
- 200 Pages
Global
From €7011EUR$7,950USD£6,070GBP
- Report
- June 2024
- 200 Pages
Global
From €7011EUR$7,950USD£6,070GBP
- Report
- June 2024
- 200 Pages
Global
From €7011EUR$7,950USD£6,070GBP
- Report
- April 2024
- 143 Pages
Global
From €7011EUR$7,950USD£6,070GBP
- Drug Pipelines
- April 2024
- 40 Pages
Global
From €1102EUR$1,250USD£954GBP
- Report
- March 2024
- 174 Pages
Global
From €6614EUR$7,500USD£5,726GBP
- Report
- February 2024
- 200 Pages
Global
From €6614EUR$7,500USD£5,726GBP
- Report
- November 2023
- 30 Pages
Global
From €2866EUR$3,250USD£2,481GBP
- Drug Pipelines
- December 2022
- 30 Pages
Global
From €2866EUR$3,250USD£2,481GBP
- Report
- September 2022
- 288 Pages
Global
From €8378EUR$9,500USD£7,253GBP
- Report
- September 2022
- 239 Pages
Global
From €6614EUR$7,500USD£5,726GBP
- Report
- September 2022
- 160 Pages
Global
From €3484EUR$3,950USD£3,016GBP
- Report
- September 2022
- 144 Pages
Global
From €4189EUR$4,750USD£3,626GBP
- Report
- January 2022
- 60 Pages
Global
From €3484EUR$3,950USD£3,016GBP
- Report
- April 2020
- 80 Pages
Global
From €3484EUR$3,950USD£3,016GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more